Related Experiment Video
Updated: Jul 5, 2026

A Modified Technique for Transverse Aortic Constriction in Mice
Published on: August 18, 2022
The pathophysiology of heart failure: a tale of two old paradigms revisited
Houman Ashrafian1, Lynne Williams, Michael P Frenneaux
1Department of Cardiovascular Medicine, University of Oxford.
Insights
Despite current heart failure (HF) treatments, high mortality persists. This review explores fundamental cardiac physiology, focusing on diastolic ventricular interaction and cardiac energetics, to uncover novel therapeutic targets for improved HF outcomes.
Area of Science:
- Cardiology
- Cardiac Physiology
Background:
- Neurohumoral activation plays a detrimental role in heart failure (HF).
- Current neurohumoral antagonism strategies have reduced HF morbidity and mortality, but high rates persist.
- Novel strategies are needed to improve HF outcomes by revisiting basic cardiac physiology.
Purpose of the Study:
- To explore fundamental cardiac physiology for novel heart failure (HF) treatment targets.
- To elucidate mechanistic principles and explain therapeutic successes in HF.
- To identify new therapeutic approaches for HF management.
Main Methods:
- Review of fundamental research in cardiac physiology.
- Focus on diastolic ventricular interaction and cardiac energetics.
- Analysis of molecular to systemic levels of cardiac function.
Main Results:
- Fundamental research illuminates the Frank-Starling law.
- Explains the success of therapies like biventricular pacing in HF.
- Identifies novel therapeutic agents, such as perhexiline for energy augmentation.
Conclusions:
- Revisiting basic cardiac physiology is crucial for advancing HF treatment.
- Understanding diastolic ventricular interaction and cardiac energetics offers new therapeutic avenues.
- Novel strategies derived from fundamental research can improve outcomes in heart failure (HF).
Abstract:
Although our current appreciation of the detrimental role of neurohumoral activation in heart failure (HF) has been intellectually appealing and has led to neurohumoral antagonism that has reduced morbidity and mortality from HF, the persisting disability and death rates remain unacceptably high. In the search for novel strategies to improve on these outcomes, we must reacquaint ourselves with basic cardiac physiology at levels ranging from the molecular to the systemic in order to identify new targets for the treatment of HF. This approach has already begun to yield results; in this review, two such aspects will be focused on: diastolic ventricular interaction and cardiac energetics. These two examples will be used to illuminate how fundamental research has elucidated age-old, although mechanistically elusive, principles (for example, the Frank-Starling law), explained why existing and emerging therapeutic approaches (for example, biventricular pacing in HF) have proved successful, and successfully identified novel therapy modes (for example, perhexiline as an energy augmentation agent).
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy